Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivityJennifer L. Leddon, Timothy P. Cripe, Mark A. Currier et al.|Molecular Therapy — Oncolytics|2014Cited by 44